ReviewAging clinical and experimental research2025
Sarcopenia - the need for an Asian perspective.
Review in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Need for Harmonized Diagnostic Criteria for Sarcopenia after the AWGS 2025 Consensus.Annals of geriatric medicine and research · 2026Article
- Comment on 'Asian Reference Values for Handgrip Strength, Gait Speed, Five-Times-Sit-to-Stand Test, Muscle Mass and Calf Circumference' by Grgic et al.Journal of cachexia, sarcopenia and muscle · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcopenia research started in Asia about 25 years ago, and is now a rapidly developing field of research. The Asian Working Group in Sarcopenia was formed in 2014 with the publication of the first Consensus definition, followed and an update in 2019, with a most recent update in 2025. Cut off values used in the definition are different from those in Europe or the US, possibly due to a combination of social determinants of body composition and ethnicity. The importance of detection of sarcopenia in community and hospital settings is recognized; however a gap exists between research, public health and clinical practice in terms of case finding and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.